As of Oct 5, 2026 close
- Market cap
- $14.39B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $393.61$615.00
- Volume (live)
- -
- Avg. volume (3M)
- 234.35K
Madrigal Pharmaceuticals (MDGL) Stock Price & Financial Analysis
Madrigal Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $486.77 - $502.34 |
|---|---|
| 52-Week High | $615.00 |
| 52-Week Low | $393.61 |
| Open | $492.69 |
| Volume (last close) | 256.24K |
| Average Volume (3M) | 234.35K |
| Market Cap | 14.39B |
|---|---|
| Shares Outstanding | 29.15M |
| Price to Sales (P/S) | 11.21 |
| Price to Book (P/B) | 27.47 |
| EV/EBITDA | -47.20 |
| Revenue (TTM) | 1.28B |
|---|---|
| Net Income (TTM) | -325.10M |
| Free Cash Flow (TTM) | -206.28M |
| EPS (TTM) | $-12.61 |
| Profit Margin | -25.32% |
| Operating Margin | -25.13% |
| Return on Equity (ROE) | -62.07% |
| Debt to Equity | 0.66 |
| 50-Day MA | $520.12 |
|---|---|
| 200-Day MA | $509.78 |
| 1-Year Change | +12.97% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Madrigal Pharmaceuticals at a Glance
Madrigal Pharmaceuticals (MDGL) has a market capitalization of $14.39B. The stock trades at 11.2× sales. Over the trailing twelve months it lost $325.10M on revenue of $1.28B and burned $206.28M of free cash flow. Revenue grew 149.0% year over year.
It holds $292.73M in cash and securities against $347.75M of debt, a net debt position of $55.02M.
Madrigal Pharmaceuticals does not currently pay a dividend.
The share price is up 13.0% over the past year. At $487.72 it sits within its 52-week range of $393.61 to $615.00, below its 200-day moving average of $509.78.
Based on 14 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $683.62, 40.2% above the latest close.
Frequently Asked Questions About Madrigal Pharmaceuticals
What is the current stock price for MDGL?
As of the Oct 7, 2026 close, MDGL stock trades at $487.72. The 52-week range is $393.61–$615.00, with a day range of $486.77–$502.34.
What is the P/E ratio for MDGL?
The P/E ratio (Price-to-Earnings) for MDGL is shown in the Key Statistics section. This valuation metric helps compare Madrigal Pharmaceuticals, Inc. to industry peers.
Does MDGL pay dividends?
Madrigal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MDGL?
Based on 14 analysts, the consensus for MDGL is Buy.
What is the market cap of MDGL?
Madrigal Pharmaceuticals's market capitalization is $14.21B, classifying it as a large-cap company. Madrigal Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.